Stay updated with breaking news from Completes Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Longeveron (NASDAQ: LGVN) announced the results of its phase 1 trial for infants with a rare and serious congenital heart disease (CHD), known as hypoplastic left heart syndrome.
CAUTION - FORWARD LOOKING STATEMENTS Certain statements contained herein regarding the Company and its operations constitute "forward-looking statements" within the... | May 15, 2023
North Vancouver, British Columbia--(Newsfile Corp. - November 7, 2022) - Lion One Metals Limited (TSXV: LIO) (OTCQX: LOMLF) (ASX: LLO) ('Lion One'...
North Vancouver, Canada - Newsfile Corp. - October 4, 2022 - Lion One Metals Limited (TSXV: LIO) (OTCQX: LOMLF) (ASX: LLO) ("Lion One" or the "Company") is pleased to announce assay results from recent wide-diameter (PQ) core drilled for metallurgical test work at its Tuvatu Gold Project in Fiji.These results complement the excellent results obtained by the infill drill program...
North Vancouver, British Columbia--(Newsfile Corp. - October 4, 2022) - Lion One Metals Limited (TSXV: LIO) (OTCQX: LOMLF) (ASX: LLO) ("Lion One" or the "Company") is pleased to announce assay results